Key Proteo is a developer of a novel peptide screening for newborn babies.
Key Proteo has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in May 2023.
Key Proteo's investors include Mint Venture Partners.
Key Proteo is headquartered in Seattle, United States.
Key Proteo is a developer of a novel peptide screening for newborn babies.
Key Proteo is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Key Proteo — Funding & Investors." VCBacked, May 16, 2023, https://www.vcbacked.co/company/key-proteo. Accessed August 1, 2026.
VCBacked. (2023). Key Proteo — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/key-proteo
{{cite web |title=Key Proteo — Funding & Investors |url=https://www.vcbacked.co/company/key-proteo |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated